HER2DX in HER2-positive inflammatory breast cancer: correlative insights and comparative analysis with noninflammatory breast cancers.
Lynce F, Martínez-Sáez O, Walbaum B, Brasó-Maristany F, Waks AG, Villagrasa P, Villacampa Javierre G, Sanfeliu E, Galván P, Paré L, Anderson LM, Perou CM, Parker JS, Vivancos A, DiLullo MK, Pernas S, Winer EP, Overmoyer B, Mittendorf EA, Bueno-Muiño C, Martín M, Prat A, Tolaney SM.
Lynce F, et al. Among authors: martin m.
ESMO Open. 2025 Jan 17;10(2):104100. doi: 10.1016/j.esmoop.2024.104100. Online ahead of print.
ESMO Open. 2025.
PMID: 39826476